Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries presents second quarter 2023 financial results and operational performance, covering generic pharmaceuticals, innovative medicines including AUSTEDO and COPAXONE, and biosimilar portfolio development. The presentation addresses competitive positioning, pipeline strategies, and risk factors affecting the company's outlook in a dynamic pharmaceutical market.
earnings
37 Pages
earnings
29 Pages
Uber Technologies, Inc.
Honeywell 2Q 2023 Earnings Release | July 27
earningsearnings
27 Pages
Honeywell International Inc.
Allison Transmission Q3 2016 Earnings
earningsearnings
12 Pages
Allison Transmission